Press Release RSS Feed (opens in new window)

Press Releases

Press release year list 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
December 19, 2014
Novocure Announces Optune Now Available at more than 150 Leading Cancer Centers across the United States
PDF format download (opens in new window)
December 18, 2014
Novocure to Present at the 33rd Annual J.P. Morgan Healthcare Conference
PDF format download (opens in new window)
December 2, 2014
Novocure Announces FDA Approval of an IDE Supplement Allowing All Control Patients in its Phase III Trial in Newly Diagnosed GBM to Cross Over to Receive Tumor Treating Fields
PDF format download (opens in new window)
December 1, 2014
Interim Analysis of Novocure’s Phase III Trial in Newly Diagnosed Glioblastoma to be Presented at Japan Society For Neuro-Oncology 2014
PDF format download (opens in new window)
November 15, 2014
Novocure Announces the EF-14 Phase III Clinical Trial of Tumor Treating Fields in Patients with Newly Diagnosed Glioblastoma has been Terminated at the Interim Analysis due to Early Success
PDF format download (opens in new window)
November 11, 2014
Novocure Announces the Presentation of New Data at the 19th Annual Society of Neuro-Oncology Meeting
PDF format download (opens in new window)
November 11, 2014
Novocure Announces Optune as the New Name for the NovoTTF-100A System
PDF format download (opens in new window)
October 30, 2014
Novocure Enrolls First Patient in a Pilot Study of Tumor Treating Fields Together with Paclitaxel for the Treatment of Recurrent Ovarian Cancer
PDF format download (opens in new window)
October 29, 2014
Novocure Announces Publication of a NovoTTF Therapy Supplement in Seminars in Oncology including Analyses of its U.S. Commercial Patient Registry Dataset (PRiDe)
PDF format download (opens in new window)
September 25, 2014
Novocure™ Announces Recurrent Glioblastoma Patient Registry Dataset (PRiDe) to be Presented at ESMO and EANO 2014
PDF format download (opens in new window)
September 4, 2014
NovoTTF™-100A System Granted High Unmet Medical Need Designation by the Japanese Ministry of Health and Welfare
PDF format download (opens in new window)
August 21, 2014
Novocure Announces the Submission of a Pre-Marketing Approval Application in Japan for the NovoTTF-100A System to Treat Recurrent Glioblastoma
PDF format download (opens in new window)
July 15, 2014
Novocure Announces Commercial Launch of NovoTTF™ Therapy in Europe and Israel
PDF format download (opens in new window)
June 13, 2014
Novocure Announces Additional Data Presented from Commercial Registry
PDF format download (opens in new window)
May 19, 2014
Novocure Announces Publication of New Survival Data for Recurrent GBM
PDF format download (opens in new window)
May 8, 2014
Novocure Sponsors 2014 Brain Cancer Awareness Month
PDF format download (opens in new window)
April 3, 2014
Novocure to Present Two Abstracts at AACR
PDF format download (opens in new window)
February 18, 2014
First Commercial License of NovoTAL™ System
PDF format download (opens in new window)
January 6, 2014
Publication of Preclinical Data in Pancreatic Cancer
PDF format download (opens in new window)